Benzodiazepines, benzodiazepine receptor agonists and some antidepressants are effective in the short-term treatment of insomnia (≤4 weeks weak recommendation, moderate-quality evidence). A pharmacological intervention can be offered if cognitive behavioural therapy for insomnia is not sufficiently effective or not available. Cognitive behavioural therapy for insomnia is recommended as the first-line treatment for chronic insomnia in adults of any age (strong recommendation, high-quality evidence).
#Acute insomnia treatment guidelines professional
periodic limb movement disorder, sleep-related breathing disorders), in treatment-resistant insomnia, for professional at-risk populations and when substantial sleep state misperception is suspected (strong recommendation, high-quality evidence). Polysomnography can be used to evaluate other sleep disorders if suspected (i.e. blood tests, electrocardiogram, electroencephalogram strong recommendation, moderate- to high-quality evidence). The diagnostic procedure for insomnia, and its co-morbidities, should include a clinical interview consisting of a sleep history (sleep habits, sleep environment, work schedules, circadian factors), the use of sleep questionnaires and sleep diaries, questions about somatic and mental health, a physical examination and additional measures if indicated (i.e. The GRADE (Grading of Recommendations Assessment, Development and Evaluation) system was used to grade the evidence and guide recommendations. The target audience for this guideline includes all clinicians involved in the management of insomnia, and the target patient population includes adults with chronic insomnia disorder. The guideline is based on a systematic review of relevant meta-analyses published till June 2016. This European guideline for the diagnosis and treatment of insomnia was developed by a task force of the European Sleep Research Society, with the aim of providing clinical recommendations for the management of adult patients with insomnia. 24 Department of Neurology, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark.23 Centre for Sleep Disorders in Children and Adolescents, General Hospital Celje, Ljubljana, Slovenia.22 Institute for Pneumology, Medical Faculty, University of Bucharest, Bucharest, Romania.21 Sleep Measurements, National University Hospital of Iceland, Reykjavik, Iceland.20 Burnasyan Federal Medical Biophysical Center of the Federal Medical Biological Agency, Moscow, Russia.19 Sleep Medicine Center and Third Department of Psychiatry, Institute of Psychiatry and Neurology, Warsaw, Poland.18 Sleep Center Pfalzklinikum, Klingenmünster, Germany.17 Multidisciplinary Sleep Disorders Centre, Antwerp University Hospital and University of Antwerp, Edegem-Wilrijk, Belgium.16 Sleep Medicine Centre, Kempenhaeghe Foundation, Heeze, The Netherlands.15 National Institute for Health and Welfare Helsinki, Helsinki, Finland.14 Department of Medicine and Surgery, University of Parma, Parma, Italy.13 University Hospital of Psychiatry, Bern, Switzerland.12 Centre du Sommeil et de la Vigilance et EA 7330 VIFASOM, Université Paris Descartes, Clinic Hotel-Dieu, Sorbonne Paris Cité, APHP, HUPC, Hotel Dieu de Paris, Paris, France.11 Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.10 Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden.9 Centro de Medicina de Sono, Hospital Cuf, Porto, Portugal.8 Stavanger University Hospital, Stavanger, Norway.7 Sleep Research Institute Madrid, Madrid, Spain.6 Sleep and Circadian Neuroscience Institute, Nuffield Department of Clinical Neuroscience at the University of Oxford, Oxford, UK.5 Northumbria Sleep Research Laboratory, Northumbria University, Newcastle, UK.4 Institute of Clinical Neurophysiology, University Medical Center Ljubljana, Ljubljana, Slovenia.3 Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway.2 University Hospital for Neurology, Inselspital Bern, Bern, Switzerland.
0 kommentar(er)
